These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9833563)

  • 1. [Acquired von Willebrand disease].
    Matsuda J
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):532-4. PubMed ID: 9833563
    [No Abstract]   [Full Text] [Related]  

  • 2. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet-type von Willebrand disease].
    Takahashi H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):485-7. PubMed ID: 9833550
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome: from pathophysiology to management.
    Veyradier A; Jenkins CS; Fressinaud E; Meyer D
    Thromb Haemost; 2000 Aug; 84(2):175-82. PubMed ID: 10959686
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
    Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
    Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type 2 von Willebrand disease].
    Takahashi H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):479-82. PubMed ID: 9833548
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent acquisitions in acquired and congenital von Willebrand disorders.
    Franchini M; Lippi G
    Clin Chim Acta; 2007 Feb; 377(1-2):62-9. PubMed ID: 17140556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type 3 von Willebrand disease].
    Takahashi H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):483-4. PubMed ID: 9833549
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.
    van Genderen PJ; Terpstra W; Michiels JJ; Kapteijn L; van Vliet HH
    Thromb Haemost; 1995 May; 73(5):891-2. PubMed ID: 7482422
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acquired Von Willebrand syndrome].
    Staal-Viliare A; Didion J; Rio Y
    Ann Biol Clin (Paris); 2006; 64(3):299-302. PubMed ID: 16698568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired von Willebrand disease: management of labor and delivery with intravenous dexamethasone, continuous factor concentrate, and immunoglobulin infusion.
    Lipkind HS; Kurtis JD; Powrie R; Carpenter MW
    Am J Obstet Gynecol; 2005 Jun; 192(6):2067-70. PubMed ID: 15970901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Barthels M; Budde U
    Hamostaseologie; 2005 Nov; 25(4):367-75. PubMed ID: 16395486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inborn and acquired von Willebrand disease].
    Schneppenheim R; Budde U
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2N von Willebrand disease.
    Mazurier C; Hilbert L
    Curr Hematol Rep; 2005 Sep; 4(5):350-8. PubMed ID: 16131435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
    Franchini M; Montagnana M; Lippi G
    Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of acquired von Willebrand syndrome with AL amyloidosis.
    Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
    Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classification.
    Hashemi Soteh SM; Anson J; Inbal A; Peake IR; Goodeve AC
    Haemophilia; 2008 May; 14(3):621-4. PubMed ID: 18384353
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired von Willebrand syndrome].
    Sucker C; Stockschläder M; Zotz RB; Scharf RE
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1581-5. PubMed ID: 15243910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.